Log in
Enquire now

List of Prometheus Laboratories patents

List of Prometheus Laboratories patents
List of ELECTROCHEMICAL OXYGEN CONCEPTS INC patents
List of Samson AG patents
List of University of Plymouth patents
List of companies in Pine Brook Partners's investment portfolio
List of Entrepreneur First London 11 companies
Patents where
Current Assignee
Name
is
Prometheus LaboratoriesPrometheus Laboratories
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7908091 Methods of predicting and monitoring tyrosine kinase inhibitor therapy

Patent 7908091 was granted and assigned to Prometheus Laboratories on March, 2011 by the United States Patent and Trademark Office.

Prometheus Laboratories
Prometheus Laboratories
United States Patent and Trademark Office
United States Patent and Trademark Office
7908091
March 15, 2011
‌
US Patent 7138250 Method of determining thiopurine methyltransferase activity

Patent 7138250 was granted and assigned to Prometheus Laboratories on November, 2006 by the United States Patent and Trademark Office.

Prometheus Laboratories
Prometheus Laboratories
United States Patent and Trademark Office
United States Patent and Trademark Office
7138250
November 21, 2006
‌
US Patent 7582282 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics

Patent 7582282 was granted and assigned to Prometheus Laboratories on September, 2009 by the United States Patent and Trademark Office.

Prometheus Laboratories
Prometheus Laboratories
United States Patent and Trademark Office
United States Patent and Trademark Office
7582282
September 1, 2009
‌
US Patent 11435347 Methods for prediction of anti-TNF α drug levels and autoantibody formation

Prometheus Laboratories
Prometheus Laboratories
Prometheus Laboratories
Prometheus Laboratories
United States Patent and Trademark Office
United States Patent and Trademark Office
11435347
September 6, 2022
‌
US Patent 7759079 Methods of diagnosing inflammatory bowel disease

Patent 7759079 was granted and assigned to Prometheus Laboratories on July, 2010 by the United States Patent and Trademark Office.

Prometheus Laboratories
Prometheus Laboratories
United States Patent and Trademark Office
United States Patent and Trademark Office
7759079
July 20, 2010
‌
US Patent 11160863 Methods of disease activity profiling for personalized therapy management

Patent 11160863 was granted and assigned to Prometheus Laboratories on November, 2021 by the United States Patent and Trademark Office.

Prometheus Laboratories
Prometheus Laboratories
Prometheus Laboratories
Prometheus Laboratories
United States Patent and Trademark Office
United States Patent and Trademark Office
11160863
November 2, 2021
‌
US Patent 8114616 Methods for diagnosing irritable bowel syndrome

Patent 8114616 was granted and assigned to Prometheus Laboratories on February, 2012 by the United States Patent and Trademark Office.

Prometheus Laboratories
Prometheus Laboratories
United States Patent and Trademark Office
United States Patent and Trademark Office
8114616
February 14, 2012
‌
US Patent 7873479 Methods of diagnosing inflammatory bowel disease

Patent 7873479 was granted and assigned to Prometheus Laboratories on January, 2011 by the United States Patent and Trademark Office.

Prometheus Laboratories
Prometheus Laboratories
United States Patent and Trademark Office
United States Patent and Trademark Office
7873479
January 18, 2011
‌
US Patent 7695908 Methods for predicting methotrexate polyglutamate levels using pharmacogenetics

Patent 7695908 was granted and assigned to Prometheus Laboratories on April, 2010 by the United States Patent and Trademark Office.

Prometheus Laboratories
Prometheus Laboratories
United States Patent and Trademark Office
United States Patent and Trademark Office
7695908
April 13, 2010
‌
US Patent 7943328 Method and system for assisting in diagnosing irritable bowel syndrome

Patent 7943328 was granted and assigned to Prometheus Laboratories on May, 2011 by the United States Patent and Trademark Office.

Prometheus Laboratories
Prometheus Laboratories
United States Patent and Trademark Office
United States Patent and Trademark Office
7943328
May 17, 2011
‌
US Patent 7670764 Methods of diagnosing tissue fibrosis

Patent 7670764 was granted and assigned to Prometheus Laboratories on March, 2010 by the United States Patent and Trademark Office.

Prometheus Laboratories
Prometheus Laboratories
United States Patent and Trademark Office
United States Patent and Trademark Office
7670764
March 2, 2010
‌
US Patent 8163499 Drug selection for breast cancer therapy using antibody-based arrays

Patent 8163499 was granted and assigned to Prometheus Laboratories on April, 2012 by the United States Patent and Trademark Office.

Prometheus Laboratories
Prometheus Laboratories
United States Patent and Trademark Office
United States Patent and Trademark Office
8163499
April 24, 2012
‌
US Patent 6921667 Methods for direct detection of individual methotrexate metabolites

Patent 6921667 was granted and assigned to Prometheus Laboratories on July, 2005 by the United States Patent and Trademark Office.

Prometheus Laboratories
Prometheus Laboratories
United States Patent and Trademark Office
United States Patent and Trademark Office
6921667
July 26, 2005
‌
US Patent 6986995 Methods of diagnosing liver fibrosis

Patent 6986995 was granted and assigned to Prometheus Laboratories on January, 2006 by the United States Patent and Trademark Office.

Prometheus Laboratories
Prometheus Laboratories
United States Patent and Trademark Office
United States Patent and Trademark Office
6986995
January 17, 2006
14 results
0 selected
14 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us